SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a trending topic following its latest financial results, which indicated pressure on gross margins and a decline in sales within the crucial China market, leading to a divided investor sentiment. The community is actively debating whether current valuations present a 'buy the dip' opportunity for the iconic brand or if intensifying competition and strategic challenges signal a prolonged period of underperformance.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to recent analyst upgrades and widespread discussion surrounding its significant advancements in autonomy and software, including expanding hands-free driving capabilities and plans for in-house AI chips. The community is buzzing with optimism, drawing comparisons to past EV growth trajectories and highlighting the company's long-term potential in the evolving electric vehicle and self-driving technology landscape. This has spurred expectations for continued institutional interest and a potential short squeeze, further amplified by anticipation for its upcoming R2 vehicle.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber (WYFI) is trending after announcing a substantial 10-year, $865 million colocation agreement with Nscale for its NC-1 AI data center campus. The community is buzzing with bullish sentiment, viewing this as a significant step in providing critical AI-ready infrastructure and anticipating substantial stock appreciation amidst high sector demand. This deal is widely seen as a major catalyst, improving revenue visibility and fueling discussions of potential short squeezes.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as the community eagerly anticipates potential federal cannabis rescheduling to Schedule III, a move widely expected to eliminate the burdensome 280E tax and unlock significant profitability for U.S. multi-state operators. Despite market volatility and some "sell the news" reactions, sentiment remains highly bullish, with investors highlighting GTBIF's strong fundamentals and growing presence in the cannabis beverage market as key drivers poised to attract institutional capital.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors hotly debate a lawsuit filed against alleged manipulators, with strong opinions on whether management is effectively addressing stock undervaluation through promised buybacks. The community discussion also centers on the phased rollout of a large AI data center contract and a recent Nobel Sustainability Trust nomination, as many question market integrity and management's actions amidst persistent share price pressure.

PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland.

PDD Holdings Inc - ADR

Pinduoduo Inc.

Pinduoduo is trending following its latest earnings insights, which showed stronger profitability but also highlighted concerns around moderated revenue growth and intensifying market competition. Community discussions reveal a strong underlying bullish sentiment, with many investors anticipating continued upside driven by global e-commerce expansion through Temu, despite the tempered outlook. This creates a fascinating divergence in perception, with significant options activity suggesting expectations for substantial price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to its announced merger with fusion power firm TAE Technologies, valued at over $6 billion. This strategic pivot into fusion energy, with its long-term potential for powering AI, is generating significant discussion among investors, ranging from excitement for a potential industry breakthrough to skepticism over its viability and concerns about the company's past volatility and valuation.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is a hot topic following its significant strategic pivot, securing substantial funding to transition its business toward an AI-first blockchain and crypto treasury strategy. The community is buzzing, anticipating a rapid upward move given the company's low float and perceived undervaluation after this transformative rebrand to ZeroStack. While many view this as a high-growth opportunity leveraging advanced AI technology, others remain cautious about the rapid shift.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending amid sharp debate following a significant decline, with many investors perceiving it as deeply undervalued given its critical role in AI infrastructure and strong revenue projections. The community is discussing whether the current price reflects a compelling buying opportunity fueled by relentless AI server demand or if persistent concerns over past performance, margin pressures, and broader sector caution will lead to further downside, despite high institutional interest and oversold technicals.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is actively discussed following the executive order to reclassify cannabis to Schedule III, a significant policy shift that the company is leveraging to advance its U.S. medical cannabis operations through its newly formed Tilray Medical USA unit. Despite sector-wide volatility interpreted by some as a "sell the news" event, many in the community emphasize the long-term benefits for profitability and institutional investment stemming from this historic regulatory change.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Addenda Capital Inc. Boosts Stock Position in Pfizer Inc. $PFE

Addenda Capital Inc. grew its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 26.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission...

Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Analysts

Pfizer Inc. (NYSE:PFE - Get Free Report) has earned an average recommendation of "Hold" from the nineteen brokerages that are currently covering the company, MarketBeat reports. One investment...

3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment

J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.

Pfizer (NYSE:PFE) Trading Down 1.9% - Time to Sell?

Pfizer (NYSE:PFE) Stock Price Down 1.9% - Here's Why...

Best Dividend Stocks To Watch Today - December 17th

Direxion Daily TSLA Bull 2X Shares, Comcast, and Pfizer are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that...

<ul class="summary-bullets"><li>The talks follow the administration’s push to lower U.S. drug prices using trade and regulatory leverage.</li><li>Pfizer and AstraZeneca have already reached agreements, while several other major drugmakers are still weighing potential deals.</li><li>Novartis and Roche have highlighted U.S. investment and manufacturing commitments.</li></ul><p>Novartis' U.S.-listed stock rose on Wednesday as investors weighed reports of impending U.S. drug pricing deals tied to the company.</p><p>The announcement is expected as soon as Friday and could include Roche, though details are still being finalized and additional drugmakers may be added, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-17/novartis-roche-near-us-drug-price-deal-in-easing-of-swiss-trade-tensions">report</a> by Bloomberg.</p><h2 class="st-heading-2"><strong>Trump’s Push On Drug Prices</strong></h2><p>In August,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-turns-up-heat-on-big-pharma-ce-os-to-slash-drug-prices-within-60-days-but-retail-traders-don-t-flinch/chr3jLYRdGW">Trump sent letters to 17 pharmaceutical companies</a> demanding that they cut prices for U.S. government insurance programs and align domestic pricing more closely with what patients pay in other developed countries. The letters also called for companies to make medicines available through a Trump-branded direct-to-consumer platform and commit to not charging Americans more than foreign markets under a “most-favored-nation” pricing framework.</p><p>In exchange, companies were offered multiyear relief from threatened tariffs and some potential regulatory measures. The administration has said it is using trade policy as leverage to force price reductions, arguing that Americans pay more than triple what patients in other developed nations pay for the same drugs.</p><h2 class="st-heading-2"><strong>Who Has And Hasn’t Cut Deals</strong></h2><p>Pfizer and AstraZeneca have already struck agreements with the administration in recent months, but many other drugmakers are still on the sidelines. Companies such as AbbVie, Bristol-Myers Squibb, Gilead Sciences, Amgen, Johnson &amp; Johnson, Merck, Regeneron Pharmaceuticals and Sanofi have yet to announce any deals.</p><p>Novartis said in a statement to Bloomberg it is in talks with the administration and is committed to lowering U.S. drug costs while addressing price gaps with other developed countries. Meanwhile, Roche’s Genentech unit said it supports efforts to reduce U.S. prices while urging other nations to better reward biopharmaceutical innovation.</p><p>The White House cautioned that no deal is final. “Until officially announced by President Trump or the Administration, any reporting about potential dealmaking is speculation,” spokesman Kush Desai told the news outlet.</p><h2 class="st-heading-2"><strong>Manufacturing Commitments&nbsp;</strong></h2><p>Domestic manufacturing has played a central role in negotiations. Novartis has stepped up its U.S. footprint, with CEO Vas Narasimhan recently attending the opening of a new manufacturing facility in North Carolina alongside FDA Commissioner Marty Makary.</p><p>The company plans to invest $23 billion in the U.S. over the next five years and generate about 41% of its revenue from the market, led by drugs such as Entresto. Roche has also committed to expanding in the U.S., pledging $50 billion in investment and deriving nearly half of its revenue from the country, driven by treatments including Ocrevus and Tecentriq.</p><h2 class="st-heading-2"><strong>How Did Stocktwits Users React?</strong></h2><p>On Stocktwits, retail sentiment for Novartis was ‘bearish’ with ‘low’ message volume, while Roche was ‘bullish’ amid ‘high’ message volume.</p><p>So far this year,&nbsp;<a href="https://stocktwits.com/symbol/NVS">Novartis’ U.S.-listed shares</a> have risen 42%, while&nbsp;<a href="https://stocktwits.com/symbol/RHHBY">Roche’s U.S.-listed stock</a> has also gained 45% over the same period.</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

In this photo illustration, the Novartis company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Equity

Promising Pharmaceutical Stocks To Watch Now - December 17th

Eli Lilly and Company, Pfizer, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded...

Medical Stocks To Research - December 17th

Eli Lilly and Company, UnitedHealth Group, Pfizer, Johnson & Johnson, Boston Scientific, Thermo Fisher Scientific, and AbbVie are the seven Medical stocks to watch today, according to MarketBeat's...

If I Could Only Buy and Hold a Single Stock, This Would Be It

Key PointsLower demand for COVID-19 treatments has been hurting Pfizer's revenue...

CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy?

CorMedix's DefenCath sales and Melinta deal raise growth stakes while Puma Biotechnology's Nerlynx-led breast cancer franchise aids growth.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

PFE
Pfizer Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PFE News

PFEPfizer Inc